129 related articles for article (PubMed ID: 3441289)
1. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y.
Potter E
Neurosci Lett; 1987 Dec; 83(1-2):101-6. PubMed ID: 3441289
[TBL] [Abstract][Full Text] [Related]
2. Guanethidine blocks neuropeptide-Y-like inhibitory action of sympathetic nerves on cardiac vagus.
Potter EK
J Auton Nerv Syst; 1987 Nov; 21(1):87-90. PubMed ID: 3440821
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of long-lasting effects of sympathetic stimulation after repeated stimulation.
Hall GT; Gardner TD; Potter EK
Circ Res; 1990 Jul; 67(1):193-8. PubMed ID: 2364490
[TBL] [Abstract][Full Text] [Related]
4. Peptide YY reduces effects of sympathetic nerves and neuropeptide Y on cardiac vagal action.
Potter EK; McCloskey DI
Peptides; 1991; 12(4):805-8. PubMed ID: 1788144
[TBL] [Abstract][Full Text] [Related]
5. Sympathetic-parasympathetic interactions at the heart, possibly involving neuropeptide Y, in anaesthetized dogs.
Revington ML; McCloskey DI
J Physiol; 1990 Sep; 428():359-70. PubMed ID: 2231416
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the inhibitory roles of neuropeptide Y and galanin on cardiac vagal action in the dog.
Moriarty M; Gibbins IL; Potter EK; McCloskey DI
Neurosci Lett; 1992 May; 139(2):275-9. PubMed ID: 1376882
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs.
Mahns DA; Lacroix JS; Potter EK
J Auton Nerv Syst; 1998 Nov; 73(2-3):80-5. PubMed ID: 9862381
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y.
Warner MR; Levy MN
Circ Res; 1989 Dec; 65(6):1536-46. PubMed ID: 2582589
[TBL] [Abstract][Full Text] [Related]
9. Vagal action on atrioventricular conduction and its inhibition by sympathetic stimulation and neuropeptide Y in anaesthetised dogs.
Pirola FT; Potter EK
J Auton Nerv Syst; 1990 Sep; 31(1):1-12. PubMed ID: 2262662
[TBL] [Abstract][Full Text] [Related]
10. Cardiac vagal action and plasma levels of neuropeptide Y following intravenous injection in the dog.
Potter EK
Neurosci Lett; 1987 Jun; 77(2):243-7. PubMed ID: 3601235
[TBL] [Abstract][Full Text] [Related]
11. The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability.
Herring N; Cranley J; Lokale MN; Li D; Shanks J; Alston EN; Girard BM; Carter E; Parsons RL; Habecker BA; Paterson DJ
J Mol Cell Cardiol; 2012 Mar; 52(3):667-76. PubMed ID: 22172449
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological separation of cardio-accelerator and vagal inhibitory capacities of sympathetic nerves.
Moriarty M; Potter EK; McCloskey DI
J Auton Nerv Syst; 1993 Apr; 43(1):7-16. PubMed ID: 8315212
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria.
Serone AP; Angus JA
Br J Pharmacol; 1999 May; 127(2):383-90. PubMed ID: 10385237
[TBL] [Abstract][Full Text] [Related]
14. Desensitization by neuropeptide Y of effects of sympathetic stimulation on cardiac vagal action in anaesthetised dogs.
Moriarty M; Potter EK; McCloskey DI
J Auton Nerv Syst; 1993 Oct; 45(1):21-8. PubMed ID: 8227962
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of pre- and postjunctional responses to neuropeptide Y and sympathetic stimulation by D-myo-inositol-1,2,6-trisphosphate in the anaesthetised dog.
Potter EK; Edvinsson L; Gustafsson T
Eur J Pharmacol; 1992 Oct; 221(2-3):307-14. PubMed ID: 1426007
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.
Herring N; Lokale MN; Danson EJ; Heaton DA; Paterson DJ
J Mol Cell Cardiol; 2008 Mar; 44(3):477-85. PubMed ID: 17996892
[TBL] [Abstract][Full Text] [Related]
17. Sympathetic-parasympathetic interactions at the heart in the anaesthetised rat.
Smith-White MA; Wallace D; Potter EK
J Auton Nerv Syst; 1999 Feb; 75(2-3):171-5. PubMed ID: 10189119
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.
Serone AP; Wright CE; Angus JA
Br J Pharmacol; 1999 May; 127(1):99-108. PubMed ID: 10369461
[TBL] [Abstract][Full Text] [Related]
19. Central control of atrio-ventricular conduction and left ventricular contractility in the cat heart: Synaptic interactions of vagal preganglionic neurons in the nucleus ambiguus with neuropeptide Y-immunoreactive nerve terminals.
Blinder KJ; Moore CT; Johnson TA; John Massari V
Auton Neurosci; 2007 Jan; 131(1-2):57-64. PubMed ID: 16950661
[TBL] [Abstract][Full Text] [Related]
20. Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart.
Ilebekk A; Björkman JA; Nordlander M
J Cardiovasc Pharmacol; 2005 Oct; 46(4):474-80. PubMed ID: 16160600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
